Delivery Order SPE2DB22D2206-SPE2DB24FHA76
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$66K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The fixed-price contract, valued at $2,960.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract has a completion date of February 1, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,294.87, is a Firm Fixed Price Delivery Order for the supply of ABRAXANE 100 MG VIALS, a specialty oncology medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1P0, is for the delivery of 4565683440 units of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $18,089.40 firm fixed-price contract was awarded on September 4, 2024 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 5, 2024 and was not set aside for any specific business type. Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,375.16 contract is for the delivery of ABRAXANE 100 MG VIALS and has an ultimate completion date of March 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,288.39 firm fixed price contract is for the supply of ABRAXANE 100 MG vials, a specialty oncology medication. The award has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp for the delivery of ABRAXANE 100 mg vials, a specialty pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order with a firm fixed price of $42,197.40 and a period of performance through September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medication to support federal healthcare programs...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ABRAXANE 100 MG vials, a specialty pharmaceutical product. The contract has a ceiling value of $10,145.58 and a completion date of August 2, 2023. The contract is not designated with a set-aside requirement, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7ZM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $9,439.35 and is a firm fixed-price Delivery Order with an ultimate completion date of June 6, 2024. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...